E³ - Advanced Course: Hybrid Imaging

E³ 1819 - Hybrid imaging in prostate cancer

March 1, 09:30 - 11:00 CET

5 min
Chairpersons' introduction
23 min
PET/MR in prostate cancer incl. local staging
23 min
Theranostics in prostate cancer
  1. To name different tracers used in the assessment of patients considered for molecular radiotherapy treatments for prostate cancer.
  2. To understand functional imaging in patient selection for molecular radiotherapy in prostate cancer.
  3. To understand functional imaging in response to molecular radiotherapy.
23 min
Clinical cases: whole-body PSMA PET/CT incl. pitfalls
  1. To be familiar with the different PSMA PET radiotracers.
  2. To understand the strengths and weaknesses of PSMA imaging.
  3. To review clinical cases, focussing on potential pitfalls.
16 min
Panel discussion: Rockstar PSMA: what remains to be accomplished?